Laboratory testing services group Eurofins Scientific is set to join France’s top stock market index, buoyed by demand for COVID-19 testing.

Eurofins
ERF,
+1.48%

will replace IT tech group Atos
ATO,
+1.70%

in the CAC 40 on Sept. 17, Euronext announced. The testing company was ranked 29th by market cap as of Thursday, and its shares have surged 82% this year.

Eurofins first-half profit more than tripled to €582 million, on a 41% rise in revenue. The demand for COVID-19 testing is so strong the company also reports revenue outside the COVID-19 testing, where it delivered 17% organic growth in the first half.

Eurofins said it’s now completed over 25 million COVID-19 PCR tests since the start of the pandemic.

Atos, meanwhile, has slumped 44% this year, and recently cut its revenue and margin targets.

More broadly, European stocks rose on Friday in a quiet day of trading.

The Stoxx Europe 600
SXXP,
+0.29%

rose 0.3% to 468.88, as gainers included ASML Holding
ASML,
+2.26%
,
Siemens
SIE,
+2.22%

and Adidas
ADS,
+1.88%
.

Of the major regional indexes, the German DAX
DAX,
+0.41%

gained 0.4%, the French CAC 40
PX1,
+0.31%

increased 0.4% and the U.K. FTSE 100
UKX,
+0.38%

increased 0.4%.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News